Vibe Bioscience Ltd (TSE:VIBE)
:VIBE
Want to see TSE:VIBE full AI Analyst Report?
Total Valuation
Vibe Bioscience Ltd has a market cap or net worth of C$539.85K. The enterprise value is C$2.10M.
Market CapC$539.85K
Enterprise ValueC$2.10M
Share Statistics
Vibe Bioscience Ltd has 10,796,989 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,796,989
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Vibe Bioscience Ltd’s return on equity (ROE) is 0.32 and return on invested capital (ROIC) is -9.38%.
Return on Equity (ROE)0.32
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-9.38%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee159.38K
Profits Per Employee-22.30K
Employee Count110
Asset Turnover1.60
Inventory Turnover14.35
Valuation Ratios
The current PE Ratio of Vibe Bioscience Ltd is ―. Vibe Bioscience Ltd’s PEG ratio is 0.00283.
PE Ratio―
PS Ratio0.02
PB Ratio-0.06
Price to Fair Value-0.06
Price to FCF25.17
Price to Operating Cash Flow3.28
PEG Ratio0.00283
Income Statement
In the last 12 months, Vibe Bioscience Ltd had revenue of 17.53M and earned -2.45M in profits. Earnings per share was -0.23.
Revenue17.53M
Gross Profit6.95M
Operating Income461.80K
Pretax Income-416.13K
Net Income-2.45M
EBITDA1.43M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was 120.92K and capital expenditures -63.77K, giving a free cash flow of 57.14K billion.
Operating Cash Flow120.92K
Free Cash Flow57.14K
Free Cash Flow per Share<0.01
Dividends & Yields
Vibe Bioscience Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.43
52-Week Price Change0.00%
50-Day Moving Average0.04
200-Day Moving Average0.06
Relative Strength Index (RSI)34.56
Average Volume (3m)6.19K
Important Dates
Vibe Bioscience Ltd upcoming earnings date is May 28, 2026, TBA (Confirmed).
Last Earnings DateApr 22, 2026
Next Earnings DateMay 28, 2026
Ex-Dividend Date―
Financial Position
Vibe Bioscience Ltd as a current ratio of 0.19, with Debt / Equity ratio of -32.27%
Current Ratio0.19
Quick Ratio0.15
Debt to Market Cap3.40
Net Debt to EBITDA1.19
Interest Coverage Ratio3.15
Taxes
In the past 12 months, Vibe Bioscience Ltd has paid 2.04M in taxes.
Income Tax2.04M
Effective Tax Rate-4.89
Enterprise Valuation
Vibe Bioscience Ltd EV to EBITDA ratio is 1.49, with an EV/FCF ratio of 124.55.
EV to Sales0.12
EV to EBITDA1.49
EV to Free Cash Flow124.55
EV to Operating Cash Flow33.64
Balance Sheet
Vibe Bioscience Ltd has C$753.51K in cash and marketable securities with C$2.46M in debt, giving a net cash position of -C$1.71M billion.
Cash & Marketable SecuritiesC$753.51K
Total DebtC$2.46M
Net Cash-C$1.71M
Net Cash Per Share-C$0.16
Tangible Book Value Per Share-C$0.80
Margins
Gross margin is 43.17%, with operating margin of 2.63%, and net profit margin of -13.99%.
Gross Margin43.17%
Operating Margin2.63%
Pretax Margin-2.37%
Net Profit Margin-13.99%
EBITDA Margin8.17%
EBIT Margin2.63%
Analyst Forecast
The average price target for Vibe Bioscience Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast38.01%
EPS Growth Forecast63.04%